Skip to main content
Riken Vitamin Co., Ltd. logo

Riken Vitamin Co., Ltd. — Investor Relations & Filings

Ticker · 4526 ISIN · JP3972600005 T Manufacturing
Open in API
Filings indexed 102 across all filing types
Latest filing 2024-02-09 Report Publication Anno…
Country JP Japan
Listing T 4526

About Riken Vitamin Co., Ltd.

https://www.rikenvitamin.jp/en/

Riken Vitamin Co., Ltd. develops and manufactures a wide range of products based on its core technologies of extraction, refinement, and concentration, originally established through the commercialization of natural Vitamin A. The company's portfolio includes food ingredients and improvers such as emulsifiers and stabilizers for the processed food industry, as well as natural extracts, seasonings, and vitamins. It also manufactures and sells commercial and consumer food products, including dressings and seaweed-based items. Riken Vitamin leverages its expertise in effectively utilizing natural materials to provide solutions that enhance food quality, safety, and nutritional value for both industrial clients and household consumers.

Recent filings

Filing Released Lang Actions
確認書
Report Publication Announcement Classification · 100% confidence The document text contains the header "第３四半期報告書" (Third Quarter Report) and specifies a reporting period: "第88期第３四半期（自2023年10月１日 至2023年12月31日）". It also includes confirmation statements regarding the appropriateness of the filing content, referencing the Financial Instruments and Exchange Act ("金融商品取引法"). This structure is characteristic of a comprehensive quarterly financial report in Japan, which corresponds to the definition of an Interim/Quarterly Report (IR). The document length is very short (561 chars), but the content is the substance of the report confirmation, not just an announcement of publication, making IR the most appropriate classification over RPA or RNS.
2024-02-09 Japanese
四半期報告書－第88期第3四半期(2023/10/01－2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Riken Vitamin Co., Ltd., covering the third quarter of the 88th fiscal year (period ending December 31, 2023). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as management analysis and notes. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. 9M 2024
2024-02-09 Japanese
臨時報告書
Regulatory Filings Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is submitted to the Kanto Local Finance Bureau Director on February 1, 2024. The content explicitly states that the filing is based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and related regulations, due to an event significantly impacting the company's financial condition, operating results, and cash flow. The event detailed is the sale of investment securities resulting in a gain of 1,895 million yen to be recorded as extraordinary income in the fourth quarter of the fiscal year ending March 2024. This structure—a formal, mandatory filing detailing a significant, non-periodic financial event (like a major asset sale or acquisition)—is characteristic of a general regulatory disclosure in Japan that doesn't fit the specific US GAAP/SEC forms (like 10-K or ER). Given the options, this is a general regulatory filing that doesn't match the specific definitions for AGM, 10-K, AR, ER, IR, etc. Therefore, the most appropriate general category for a miscellaneous, mandatory regulatory filing that doesn't fit elsewhere is 'Regulatory Filings' (RNS).
2024-02-01 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of the Second Quarter Report (Interim Report). While it references the quarterly report, the document itself is a formal regulatory filing confirming the validity of the financial statements submitted to the Kanto Local Finance Bureau. Given it is a specific regulatory compliance document required by Japanese law for financial reporting, it falls under the Regulatory Filings category.
2023-11-10 Japanese
四半期報告書－第88期第2四半期(2023/07/01－2023/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Riken Vitamin Co., Ltd. in accordance with the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, including the balance sheet and income statement for the second quarter of the fiscal year ending March 31, 2024. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. Q2 2024
2023-11-10 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically confirming the accuracy of the contents of the First Quarter Report (第１四半期報告書). Since this is a regulatory filing confirming the validity of a quarterly report rather than the quarterly report itself, and it does not fit into specific categories like AGM or M&A, it is classified as a Regulatory Filing (RNS).
2023-08-10 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.